Objective ALBYN MEDICAL has developed, in cooperation with the Chemnitz University of Technology and the University Hospital of Cologne (Germany), a specific diagnostic system for the Overactive Bladder syndrome. This diagnostic device is implanted by cystoscopy and measures the bladder pressure autonomously, relating the bladder pressure with the urination, controlled or not, and it determines if the pressure rise appears only when a voluntary urination occurs or if also occurs other times as in the accidental urine loss.Thanks to the new diagnostic device a reliable diagnostic evaluation is obtained and thus high treatment costs of the current Overactive Bladder over-diagnosis are avoided improving the sustainability of the European Health and Care systems. Fields of science medical and health sciencesclinical medicineoncologybladder cancersocial scienceseconomics and businessbusiness and managementbusiness models Programme(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.3. - Treating and managing disease Topic(s) PHC-12-2014-1 - Clinical research for the validation of biomarkers and/or diagnostic medical devices Call for proposal H2020-SMEInst-2014-2015 See other projects for this call Sub call H2020-SMEINST-1-2014 Funding Scheme SME-1 - SME instrument phase 1 Coordinator ALBYN MEDICAL, S.L. Net EU contribution € 50 000,00 Address Poligono Industrial de Cordovilla D1 31191 Cordovilla Spain See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Noreste Comunidad Foral de Navarra Navarra Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 71 429,00
